Antidepressant mechanisms of a food-medicine homologous compound concentrate from Hemerocallis citrina Baroni: Regulation of PI3K/AKT/BDNF signaling pathway in preclinical models

Read full text Summarise with VIRAT
Authors: Jialin Li, Chenxin Sun, Fengzhong Wang, Bei Fan, Xue Bai, Ziyang Wu, Xin Shi, Bolin Fan, Xiang Zou, Jing Sun
Cited by: 0
References: 47

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

A B S T R A C T Objective To determine the optimal dosing ratio of the herbal components within compound Hemerocallis citrina Baroni ( H . citrina ) extract concentrate (CHEC), evaluate its antidepressant effects in zebrafish and mouse models of depression, and elucidate the underlying mechanisms with a particular focus on the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/brain-derived neurotrophic factor (BDNF) signaling pathway using network pharmacology and molecular biology approaches. Methods The optimal CHEC formulation was screened using a zebrafish model of reserpine-induced depression. To assess neuroinflammation and monoamine neurotransmitter levels, the levels of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, dopamine, and 5-hydroxytryptamine in zebrafish brain tissues were measured using enzyme-linked immunosorbent assay kits. Active constituents were identified by liquid chromatography-tandem mass spectrometry and potential targets were predicted using the Swiss Target Prediction database. A traditional Chinese medicine–active ingredient–target network and a protein–protein interaction network were constructed, followed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses to explore potential mechanisms. A mouse model of depression was subsequently established using chronic restraint stress (CRS) combined with intraperitoneal lipopolysaccharide injection. The antidepressant effects of CHEC were assessed through behavioral tests, quantification of monoamine neurotransmitters and inflammatory cytokines, histopathological examination of hippocampal neurons using hematoxylin and eosin staining, and western blot analysis of PI3K/AKT/BDNF pathway-related proteins. Results CHEC significantly alleviated depressive-like behaviors in CRS mice, as demonstrated by behavioral assessments. Treatment reduced levels of pro-inflammatory cytokines and restored monoamine neurotransmitter concentrations. Histological analysis revealed attenuation of hippocampal neuronal damage. Furthermore, CHEC significantly modulated the PI3K/AKT/BDNF signaling pathway in the hippocampus of depressive-like mice. Conclusion CHEC exerts antidepressant-like effects by suppressing inflammatory cytokines, including tumor necrosis factor-alpha, IL-6, and IL-1β; enhancing dopamine and BDNF levels; and regulating the PI3K/AKT/BDNF signaling pathway. These findings provide mechanistic evidence supporting the therapeutic potential of CHEC for depression.

Fields of Study & Subjects

Medicinal Plant Extracts Effects Treatment of Major Depression Medicinal Plants and Bioactive Compounds

Publication details

Journal / source
Journal of Traditional Chinese Medical Sciences
Volume
13
Issue
2
Pages
163–178
Publication date
21 March 2026
Language
EN